May Barometer of financial markets outlook

The Bank of England is likely to cut at the same time. Our modified Taylor rule model suggests the central bank has significant room to ease, with scope to deliver as many as four or five cuts by year end. That should provide further support to the UK economy, which now seems to have recovered from recessionary conditions. 

In the US, by contrast, rate cuts are likely to be delayed at least until September. The inflation backdrop is mixed, with core goods inflation contracting, but core services inflation moving in the opposite direction – core ex rents inflation increased to 6 per cent year-on-year in March. This reflects the US’s GDP growth trajectory, with services propping up the economy while most other sectors display weaker, late-cycle dynamics (for example, retail sales were flat last month while consumption of goods contracted in the first quarter this year). The resilience in services consumption is unlikely to endure if households increase their savings to more normal levels: currently households are saving 3.5 per cent of their disposable income, when the average is usually 7 per cent. Furthermore, excess savings built in the aftermath of pandemic-induced stimulus will be depleted by the end of this month.

Our liquidity indicators are broadly neutral for global risk assets; expectations for an easing of monetary have been recently been pushed further out into the future, nowhere more so than in the US. And while commercial banks in Europe are increasingly willing and able to lend, demand for credit in the private sector is is unlikely to pick up without an easing of policy.

One exception is China, where a mini easing cycle offers a partial offset to longer-term deleveraging pressures. We expect monetary policy there to remain easy but restrained – irrigating the economy rather than flooding it with broader monetary stimulus.

In terms of valuations, global equities are looking slightly more attractive following the market's recent weakness – albeit still expensive relative to their performance range over the past 20 years. Furthermore, corporate earnings momentum remains positive across developed markets (see Fig. 2). Europe, UK and Switzerland are all cheap according to our model, supporting our overweight positions in those regions.

In fixed income, valuations look especially attractive for US Treasuries as short-term rates have climbed back to cyclical peaks.

In contrast, gold has moved further into extremely expensive territory. At  a time of easing inflationary pressures and an improving economic outlook, we believe such valuations are no longer justified.

Technical indicators are also flashing red on gold: the market is overbought, positioning is stretched and surveys show that the proportion of investors seeing gold as over-valued is the highest since August 2020.

In contrast, technical indicators are now looking friendlier for equities after the recent pullback – positioning in stocks among investors, for example, is less bullish, increasing the scope for gains. 

Another positive sign is that gains in equities have recently broadened out across industries and sectors,  meaning that outperformance is no longer concentrated in a handful of stocks. This reduces the risk of a sharp pullback.

We also upgrade UK stocks to neutral from underweight. Earnings dynamics for domestic UK-listed companies are supported by expected interest rate cuts by the Bank of England. What is more, the UK equity market offers exposure to cyclical stocks such as mining and energy, which are particularly attractive at this point in the business cycle.

We remain overweight Swiss equities, a market which is home to a disproportionately high number of quality companies.

The Swiss market as whole may have advanced a disappointing 6 per cent this year, held back by a group of three underperformers – food company Nestle and pharmaceutical firms Novartis and Roche -- which make up nearly half of the index and have fallen nearly 10 per cent since last year.

On a market-cap weighted basis, however, the rest of the index is comfortably outperforming, up 25 per cent from its October low. What is more, easier monetary policy from the Swiss National Bank – which cut interest rates well ahead of its peers – should cushion the economy in the coming year.

We also remain overweight Japanese stocks. Strong company earnings and encouraging progress on corporate governance reforms make Japanese equity one of our very strongest convictions.

Elsewhere, we are neutral US stocks. The world’s biggest equity market is trading at a high valuation – it is the most expensive on our score card -- while sticky inflation may delay the timing of the Fed’s first rate cut.

As the US implied equity risk premium – an estimation of the excess return that investing in the stock market should provide over a risk-free rate – stands at well below the average at 3.3 per cent, we can expect almost no outperformance of stocks over bonds.

That said, we are reluctant to go underweight as the US offers investors exposure to the world’s leading technology and communication services companies that are enjoy strong growth.

A “Magnificent Seven” group of megacap US tech companies are likely to lead profit growth on Wall Street, although earnings results have been mixed – blockbuster earnings from Alphabet and Microsoft are contrasting with disappointing reports from Meta and Tesla. Nevertheless, results so far point to higher capital spending on data infrastructure. We continue to be overweight in this sector which is underpinned by attractive secular growth themes such as artificial intelligence.

The disinflationary trend looks more established in the UK, prompting us to overweight UK Gilts. By contrast, easy monetary policy has made Swiss and Japanese bonds expensive, which is why we maintain an underweight on those markets.

We remain constructive on US high grade credit which would benefit from a below-potential growth disinflationary backdrop. Short-term high yield credit also looks particularly attractive with excess return potential versus bonds given our limited expectation on duration returns; the level of carry also remains attractive. 

Although we believe in the long-term investment case for gold, we have chosen to scale back our exposure to the precious metal as part of a tactical move.  While gold is supported by demand among emerging market central banks, we believe its valuation is looking high. We have thus move to a benchmark-weighting from overweight, awaiting a better point to re-enter the market.

We also downgrade the Swiss franc to underweight. We think it is beneficial to have some upside exposure to the dollar, since, for now, the Fed is having to sit on its hands rather than ease policy. It seems sensible to swap some of the Swiss currency for dollars since the Swiss central bank has already started its easing cycle.

US equity trends weighed on other markets. Euro zone stocks lost 1.8 per cent in local currency terms on the month, Swiss stocks lost 2.5 per cent and Japanese equities 1.1 per cent. The UK equity market was a prominent outlier, gaining almost 3 per cent – the market is relatively undervalued while investors are also beginning to anticipate Bank of England rate cuts as inflation comes down and economic growth remains soft. Emerging Asian equities also performed well, up 1.8 per cent, with some hopes that the Chinese economy might be poised for a rebound.

Energy was the strongest sector performer, up 1.1 per cent on the month, while real estate dropped 6.1 per cent on fears about the persistence of high rates, while investors took some profits on an inflated IT sector, down 5.2 per cent in local currencies. 

Taking their lead from US Treasuries, government bonds fell back across the board, most losing between 1 per cent and 3 per cent on the month. Credit suffered alongside the equity markets, with US investment grade dropping some 2 per cent on the month.

^{Information, opinions and estimates contained in this document reflect a judgement at the original date of publication and are subject to risks and uncertainties that could cause actual results to differ materially from those presented herein.}